Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $499.77 ($4.8M) on 2026-09-15, disclosed to the SEC on 2026-09-16.
Scheduled sale ($4.8M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $499.77 | 780 | $390K | 8.2% |
| 2 | $500.68 | 3,711 | $1.9M | 39.0% |
| 3 | $501.66 | 2,689 | $1.3M | 28.3% |
| 4 | $502.57 | 825 | $415K | 8.7% |
| 5 | $503.80 | 845 | $426K | 8.9% |
| 6 | $504.57 | 650 |
| $328K |
| 6.9% |
| Total | $501.59 avg | 9,500 | $4.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-06 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-05 | $5.2M | — | Filing → |